December 2019—Qiagen announced the publication of a multicenter clinical study demonstrating the accuracy of its QIAstat-Dx syndromic testing solution for diagnosing the causes of acute gastroenteritis (Hannet I, et al. Eur J Clin Microbiol Infect Dis. 2019;38[11]:2103–2112).
The study evaluated 385 patient samples at university hospital laboratories across Europe and showed the QIAstat-Dx Gastrointestinal Panel was highly sensitive (98.2 percent positive) and specific (99.9 percent negative). Multiple pathogens were identified in nearly one-third of the patient samples that tested positive. The study also cited the ability of the panel to provide cycle threshold values and amplification curves to aid in interpreting results.
The QIAstat-Dx GI panel provides differential detection of more than 20 bacterial, viral, and parasitic pathogens implicated in gut infections and is available in Europe.
Qiagen, 800-426-8157